GSK seeks EU approval for diabetes drug albiglutide

03/8/2013 | Yahoo

GlaxoSmithKline submitted an application to the European Medicines Agency for approval to market its diabetes drug albiglutide. The once-weekly drug belongs to the same class as Novo Nordisk's Victoza and Amylin Pharmaceuticals' Byetta and Bydureon.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Sr. Principal Electrical Engineer - 14000008LR
San Jose, CA